Yeast β-1, 3-glucan production by an outer membrane β-1, 6-glucanase: process optimization, structural characterization and immunomodulatory activity. Issue 7 (15th March 2022)

• Record Type: Journal Article
• Authors: Qiao, Yan; Ye, Xianfeng; Zhong, Lingli; Xia, Chengyao; Zhang, Lei; Yang, Fan; Li, Yongkai; Fang, Xiaodong; Fu, Lei; Huang, Yan; Cao, Hui; Li, Zhoukun; Cui, Zhongli
• Is Part Of: Food & function. Volume 13:Issue 7(2022)
• Page Start: 3917
• Page End: 3930
• Publication Date: 2022-03-15
• Subjects: Food -- Analysis -- Periodicals; Food -- Composition -- Periodicals; Nutrition -- Periodicals; 664.07
• DOI: 10.1039/d1fo02832d
• Languages: English
• ISSNs: 2042-6496

Abstract

Abstract : Yeast β-glucan BYG that isolated from OM β-1, 6-glucanase GluM-based hydrolysis exhibits structural integrity that responsible for its favorable immunomodulatory activity. Abstract : The β-glucan from Saccharomyces cerevisiae is a potent adjuvant that exhibits a broad spectrum of biological activities and health benefits, and different processes have been established to prepare active β-glucan from yeast. However, studies concerning the effect of β-1, 6-glucanase enzymolysis on the structure and immunomodulatory activity of yeast β-1, 3-glucan are scarce. In this study, we aim to develop a novel enzymatic process for the preparation of immunologically active β-glucan (BYG) from baker's yeast using a β-1, 6-glucanase GluM. The β-1, 6-glucan in fungal cell wall was specifically hydrolyzed by GluM, and resulted in cell wall decomposition and β-glucan release. Batch production of BYG was realized with 17.8% yield, 85.3% purity and 75.4% recovery rate. Structural characterization indicated that BYG exhibits rod-like structures with natural triplex and nanoparticle-like substructures compared with the commercial Glucan 300. BYG ameliorated inflammation in a DSS-induced mouse model of colitis through inhibiting oxidative stress (NO, MDA and MPO), inflammatory mediators (NLRP3, ASC, caspase-1, iNOS and COX-2), and pro-inflammatory cytokines (IL-1β, IL-6, TNF-α, IFN-γ), increasing the expression levels of tight junction proteins (ZO-1, occludin and claudin-1) and modulating the production of gut microbiota-synthesized SCFAs compared to the control. Our results showed that yeast β-1, 3-glucan prepared with β-1, 6-glucanase exhibits structural integrity that is responsible for its favorable immunomodulatory activity.